Data / Form D filings / Potrero Medical, Inc.
Potrero Medical, Inc.: Form D filings
Potrero Medical, Inc., a biotechnology company in Hayward, CA, filed 10 Form D notices with the SEC between 2014 and 2026. The latest, on May 29, 2026, reports $6.5 million sold of a $6.5 million offering to 56 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 26142 EDEN LANDING RD., Hayward, CA, 94545
- Phone
- (888) 635-7280
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1609048
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | New notice | $6,500,000 | $6,500,000 | 56 | May 8, 2026 | sec.gov | |
| Sep 2, 2025 | New notice | $5,500,000 | $2,278,241 | $3,221,759 | 29 | Aug 28, 2025 | sec.gov |
| Oct 31, 2024 | New notice | $12,000,000 | $3,200,000 | $8,800,000 | 6 | Oct 24, 2024 | sec.gov |
| Apr 10, 2023 | New notice | $24,626,726 | $17,747,111 | $6,879,615 | 99 | Mar 24, 2023 | sec.gov |
| Oct 29, 2019 | Amendment | $19,999,999 | $17,185,962 | $2,814,037 | 26 | Jun 28, 2019 | sec.gov |
| Jul 12, 2019 | New notice | $14,999,999 | $11,742,968 | $3,257,031 | 20 | Jun 28, 2019 | sec.gov |
| Jul 10, 2018 | New notice | $31,332,845 | $24,642,458 | $6,690,387 | 32 | May 25, 2018 | sec.gov |
| Aug 7, 2017 | Amendment | $12,061,558 | $7,259,254 | $4,802,304 | 21 | Aug 30, 2016 | sec.gov |
| Sep 13, 2016 | New notice | $12,061,558 | $4,839,258 | $7,222,300 | 14 | Aug 30, 2016 | sec.gov |
| May 27, 2014 | New notice | $3,900,000 | $3,900,000 | 9 | May 13, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Dewey | Director | |
| Mark Goldwasser | Director | |
| Maurice Ferre | Director | |
| Ram Reddy | Director | |
| David Matlin | Director | |
| Mike Stansky | Director | |
| Clay Heighten | Director | |
| Todd Dunn | Executive Officer | CEO |
| Khalid Ghafari | Executive Officer | CFO |
| Rich Keenan | Executive Officer | CPO |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 25, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Potrero Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.